British Study Reveals 'Master Switch' To Beat Cancer Cells

Cancer-CellIn a recent British study, it has been found that a genetic “master switch” could play significant role in reducing cancerous growth. This was found by a team from the Bristol University and the University of the West of England.

It is being believed that this study could pave way for battle against cancer as this is specially targeted to inhibit cancerous growth. Published on Monday in the U. S. journal Cancer Cell, the study has proved that how cancer cells grow faster by producing their own blood vessels. It’s being believed that mutations in one specific cancer gene can do a lot to understand how slicing is being managed. It has also been told that master switch of splicing could push the growth of cancer cells and even blood vessels also grow at faster rate.

The team had done a trial that revealed that inclusion of drugs could inhibit this master switch, which ultimately played crucial role in stopping blood vessel growth and blocked the growth of cancers.

"The research clearly demonstrates that it may be possible to block tumor growth by targeting and manipulating alternative splicing in patients, adding to the increasingly wide armory of potential anti-cancer therapies”, said the report.

There have been significant research work done in the field of cancer and this research has certainly added more weight to the fact that cancer could be cured. It’s being expected by the team that this research would be able to address the concerns of for cancers such as breast, prostate and kidney.

There is still need to give more attention to the underlying theory so that clinical implications could be studied and more significant results could be deduced from the same. Extensive study is being called for by the team led by Dr. Michael Ladomery, from UWE Bristol.